Speaker Profile
M.D., Ph.D., Vice President, Genomic Health, 23andMe
Biography
Dr. Noura Abul-Husn leads 23andMe's clinical strategy to integrate consumer genetics into healthcare. In addition to her leadership role at 23andMe, she is an Associate Professor at the Icahn School of Medicine at Mount Sinai. Dr. Abul-Husn is a physician scientist and expert in personalized healthcare and genomic medicine. She was the founding Chief of the Division of Genomic Medicine and Clinical Director of the Institute for Genomic Health at Mount Sinai, overseeing multidisciplinary teams of clinicians and researchers to spearhead genomic research, education, and care delivery innovation. Prior to that, she served as Director of Translational Genetics at the Regeneron Genetics Center. She is the recipient of numerous awards and has spoken and published extensively on her research spanning genomic discovery, genomic medicine, and health equity. Dr. Abul-Husn is a double board-certified Internist and Medical Geneticist. She completed her MD, PhD, and residency at Mount Sinai in New York.
Talk
Genetics: The Key to Personalized, Preventive Health
With so many individuals motivated to live longer, healthier lives, many still dont understand the power of genetics when it comes to preventive health. 23andMe offers direct-to-consumer genetic insights not readily available through traditional healthcare. Having personalized insights into ones own health risks empowers individuals to take the right actions to stay healthy, longer.
Genomic Profiling Showcase:
23andMe
23andMe is a genetics-led consumer healthcare company empowering a healthier future.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Genomic Profiling Showcase will provide a 15-30 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
